Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • nr23
    Member
    • Oct 2012
    • 42

    When to merge specify replicates

    Hi,

    I've got RNA-Seq data (pe 100bp) from several biological replicates and 11 different conditions and want to compare DE between conditions.

    I'm using the tuxedo suite (tophat, cufflinks) and wanted to know if I should run both replicates through tophat at the same time (specified as reps) , and use the output for cufflinks, or separately, and specify them as replicates in cufflinks?

    Additionally, the samples have been multiplexed (so each replicate is split over two lanes) - and I've currently merged the multiplexed reads for each replicate - do I lose power by doing this?

    Any advice would be great!

    Thanks,

    N
    Last edited by nr23; 06-05-2013, 01:49 AM.
  • mbblack
    Senior Member
    • Aug 2009
    • 245

    #2
    Keep your biological replicates separate, and treat them as replicates. Otherwise, there was little point in even running them as you will have completely obscured the biological variation amongst your samples.

    Merging all your multiplexed lanes per sample prior to mapping them is fine and then you can map them all as the single sample they represent.
    Last edited by mbblack; 05-29-2013, 04:52 AM.
    Michael Black, Ph.D.
    ScitoVation LLC. RTP, N.C.

    Comment

    • mastal
      Senior Member
      • Mar 2009
      • 666

      #3
      When to merge specify replicates

      How many lanes were used in all? Were all of the samples run in the same two lanes?

      You shouldn't combine biological replicates when running Tophat. You need the replicates in order to estimate the variance when calculating DE.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2



        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        Introduction

        The systematic characterization
        ...
        Today, 10:07 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Working...